Pharmacogenetic Testing Reports: Interpreting Gene-drug Interactions and Clinical Recommendations
About the Lecture
The lecture Pharmacogenetic Testing Reports: Interpreting Gene-drug Interactions and Clinical Recommendations by Melissa Kalensky, FNP-BC, PMHNP-BC, CNE is from the course Hormonal and Genetic Influences in Psychopharmacology.
Included Quiz Questions
Which of the following represents the three main cytochrome P450 enzymes that impact drug metabolism and psychotropic medication response?
- CYP2D6, CYP3A4, and CYP2C19
- CYP1A2, CYP2D6, and CYP3A4
- CYP2C19, CYP2C9, and CYP3A5
- CYP3A4, CYP2C9, and CYP1A2
- CYP2D6, CYP2C19, and CYP2C9
When reviewing a pharmacogenetic testing report, what is the first critical step to ensure accurate interpretation?
- Verify the patient's demographic information and sample collection details.
- Review the pharmacodynamic and pharmacokinetic implications sections.
- Analyze the smoking status for potential CYP1A2 metabolism effects.
- Identify all medications in significant gene-drug interaction category.
- Compare the patient's genetics against the standard dosing guidelines.
Author of lecture Pharmacogenetic Testing Reports: Interpreting Gene-drug Interactions and Clinical Recommendations
Melissa Kalensky, FNP-BC, PMHNP-BC, CNE
Customer reviews
5,0 of 5 stars
| 5 Stars |
|
5 |
| 4 Stars |
|
0 |
| 3 Stars |
|
0 |
| 2 Stars |
|
0 |
| 1 Star |
|
0 |
